THE NATIONAL ACADEMIES PRESS
500 Fifth Street, N.W. Washington, DC 20001
NOTICE: The working group summaries in this publication are based on working group discussions during the National Academies Keck Futures Initiative The Genomic Revolution: Implications for Treatment and Control of Infectious Disease Conference held at the Arnold and Mabel Beckman Center of the National Academies in Irvine, CA, November 10-13, 2005. The discussions in these groups were summarized by the authors and reviewed by the members of each working group. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the working groups and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
Funding for the activity that led to this publication was provided by the W.M. Keck Foundation. Based in Los Angeles, the W.M. Keck Foundation was established in 1954 by the late W.M. Keck, founder of the Superior Oil Company. The Foundation’s grant making is focused primarily on pioneering efforts in the areas of medical research, science, and engineering. The Foundation also maintains a Southern California Grant Program that provides support in the areas of civic and community services with a special emphasis on children. For more information, visit www.wmkeck.org.
International Standard Book Number 0-309-10109-3
Additional copies of this report are available from the
National Academies Press,
500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, www.nap.edu.
Copyright 2006 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America